Eficacia de los pulsos de corticoides en pacientes con síndrome de liberación de citocinas inducido por infección por SARS-CoV-2

JLC Rubio, JDL del Castillo, J de la Hera Fernández… - Medicina clinica, 2020 - Elsevier
Introducción El síndrome de liberación de citocinas (SLC) es una complicación grave de los
pacientes COVID-19. La base del tratamiento es tocilizumab. El uso de glucocorticoides (…

Tratamiento y evolución del síndrome de tormenta de citoquinas asociados a infección por SARS-CoV-2 en pacientes octogenarios

JLC Rubio, IA Millán, MM Higueras, LM Medina… - Revista Española de …, 2020 - Elsevier
Introducción El síndrome de tormenta de citoquinas (STC) es una complicación muy grave
de los pacientes con infección por SARS-CoV-2. El tratamiento y la evolución no están bien …

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts

…, F García-Hernández, JL Callejas-Rubio… - Autoimmunity …, 2012 - Elsevier
OBJECTIVE: To present a pooled analysis of the efficacy of rituximab from European cohorts
diagnosed with biopsy-proven lupus nephropathy (LN) who were treated with rituximab. …

[HTML][HTML] Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death

…, J Sánchez-Román, JL Callejas-Rubio… - Medicine, 2015 - journals.lww.com
Systemic sclerosis (SSc) is a rare, multisystem disease showing a large individual variability
in disease progression and prognosis. In the present study, we assess survival, causes of …

Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status

…, J Sánchez-Román, JL Callejas-Rubio… - Seminars in arthritis and …, 2012 - Elsevier
OBJECTIVE: To investigate the incidence of clinical and immunological characteristics of a
large cohort of Spanish patients with scleroderma (SSc) and identifying factors associated …

Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes

…, S Takei, N Kobayashi, JL Callejas-Rubio… - Annals of the …, 2015 - ard.bmj.com
<p>Familial cold autoinflammatory syndrome, Muckle-Wells syndrome (MWS), and chronic,
infantile, neurological, cutaneous and articular (CINCA) syndrome are dominantly inherited …

Successful optimization of adalimumab therapy in refractory uveitis due to Behçet's disease

…, N Ortego, JL García-Serrano, JL Callejas-Rubio… - Ophthalmology, 2018 - Elsevier
Purpose To assess efficacy, safety, and cost-effectiveness of adalimumab (ADA) therapy
optimization in a large series of patients with uveitis due to Behçet disease (BD) who achieved …

[HTML][HTML] Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A …

…, N Faro-Miguez, JL Callejas-Rubio… - Internal and emergency …, 2021 - Springer
Introduction Little evidence appears to exist for the use of anakinra, a recombinant
interleukin-1 receptor antagonist, after non-response to treatment with corticosteroids alone or …

Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: a cross-sectional study

…, M Correa-Rodríguez, JL Callejas-Rubio… - …, 2021 - academic.oup.com
Objective To analyse the influence of the Mediterranean diet (Med Diet) on SLE activity,
damage accrual and cardiovascular disease risk markers. Methods A cross-sectional study was …

Treatment of therapy-resistant sarcoidosis with adalimumab

JL Callejas-Rubio, N Ortego-Centeno… - Clinical …, 2006 - Springer
A possible role of tumor necrosis factor alpha (TNFα) in the pathomechanism of sarcoidosis
must be considered in the analysis of this disorder since elevated concentrations of this …